tradingkey.logo

Immunoprecise Antibodies Ltd

IPA
2.070USD
0.0000.00%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
95.54MCap. mercado
PérdidaP/E TTM

Immunoprecise Antibodies Ltd

2.070
0.0000.00%

Más Datos de Immunoprecise Antibodies Ltd Compañía

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.

Información de Immunoprecise Antibodies Ltd

Símbolo de cotizaciónIPA
Nombre de la empresaImmunoprecise Antibodies Ltd
Fecha de salida a bolsaJan 30, 1987
Director ejecutivoDr. Jennifer Lynne Bath, Ph.D.
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalJan 30
DirecciónIndustrious 823 Congress Ave Suite 300
CiudadAUSTIN
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal78701
Teléfono16048060626
Sitio Webhttps://www.ipatherapeutics.com/
Símbolo de cotizaciónIPA
Fecha de salida a bolsaJan 30, 1987
Director ejecutivoDr. Jennifer Lynne Bath, Ph.D.

Ejecutivos de Immunoprecise Antibodies Ltd

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Jennifer Lynne Bath, Ph.D.
Dr. Jennifer Lynne Bath, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
498.12K
--
Dr. Kamil Isaev
Dr. Kamil Isaev
Independent Director
Independent Director
3.19K
--
Mr. Dirk Witters
Mr. Dirk Witters
Independent Director
Independent Director
1.95K
--
Ms. Kari Graber
Ms. Kari Graber
Vice President - Commercial Services
Vice President - Commercial Services
700.00
--
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Director
Director
--
--
Mr. Joseph Scheffler
Mr. Joseph Scheffler
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Dr. Shuji Sato
Dr. Shuji Sato
Vice President - Innovative Solutions
Vice President - Innovative Solutions
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Jennifer Lynne Bath, Ph.D.
Dr. Jennifer Lynne Bath, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
498.12K
--
Dr. Kamil Isaev
Dr. Kamil Isaev
Independent Director
Independent Director
3.19K
--
Mr. Dirk Witters
Mr. Dirk Witters
Independent Director
Independent Director
1.95K
--
Ms. Kari Graber
Ms. Kari Graber
Vice President - Commercial Services
Vice President - Commercial Services
700.00
--
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Director
Director
--
--
Mr. Joseph Scheffler
Mr. Joseph Scheffler
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
Por negocioUSD
Nombre
Ganancia
Proporción
Project revenue
4.06M
98.40%
Cryo storage revenue
66.00K
1.60%
Product sales revenue
0.00
0.00%
Por regiónUSD
Nombre
Ganancia
Proporción
United States of America
2.40M
58.20%
Europe
900.00K
21.82%
Other
550.00K
13.34%
Australia
226.00K
5.48%
Canada
48.00K
1.16%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Project revenue
4.06M
98.40%
Cryo storage revenue
66.00K
1.60%
Product sales revenue
0.00
0.00%

Estadísticas de accionistas

Actualizado: sáb., 7 de feb
Actualizado: sáb., 7 de feb
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Charmquark TWEE
7.83%
Ingalls & Snyder LLC (Asset Management)
5.78%
Susquehanna International Group, LLP
1.07%
Bath (Jennifer Lynne)
1.07%
Renaissance Technologies LLC
0.47%
Otro
83.77%
Accionistas
Accionistas
Proporción
Charmquark TWEE
7.83%
Ingalls & Snyder LLC (Asset Management)
5.78%
Susquehanna International Group, LLP
1.07%
Bath (Jennifer Lynne)
1.07%
Renaissance Technologies LLC
0.47%
Otro
83.77%
Tipos de accionistas
Accionistas
Proporción
Corporation
7.83%
Investment Advisor/Hedge Fund
6.31%
Investment Advisor
1.38%
Individual Investor
1.21%
Hedge Fund
0.71%
Research Firm
0.18%
Venture Capital
0.08%
Bank and Trust
0.07%
Otro
82.24%

Participación institucional

Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
48
4.08M
8.74%
-217.78K
2025Q3
41
3.90M
8.45%
-302.90K
2025Q2
46
8.16M
23.11%
+1.40M
2025Q1
45
6.32M
13.81%
+742.61K
2024Q4
45
4.34M
9.53%
-1.30M
2024Q3
46
5.39M
19.68%
+72.87K
2024Q2
48
5.12M
19.96%
-156.62K
2024Q1
50
5.14M
20.20%
-196.19K
2023Q4
58
5.33M
20.96%
+124.72K
2023Q3
50
4.91M
19.67%
-438.42K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Charmquark TWEE
3.66M
7.83%
--
--
Jul 25, 2025
Ingalls & Snyder LLC (Asset Management)
2.70M
5.78%
-79.67K
-2.87%
Sep 30, 2025
Susquehanna International Group, LLP
501.70K
1.07%
-197.54K
-28.25%
Sep 30, 2025
Bath (Jennifer Lynne)
498.12K
1.07%
--
--
Aug 27, 2025
Renaissance Technologies LLC
220.48K
0.47%
+180.00K
+444.66%
Sep 30, 2025
Marshall Wace LLP
168.65K
0.36%
+168.65K
--
Sep 30, 2025
Two Sigma Investments, LP
108.93K
0.23%
+18.08K
+19.90%
Sep 30, 2025
Allianz Global Investors Asia Pacific Limited
60.00K
0.13%
+60.00K
--
Sep 30, 2025
Morgan Stanley Smith Barney LLC
55.00K
0.12%
+45.00K
+450.00%
Sep 30, 2025
XTX Markets LLC
37.39K
0.08%
-53.99K
-59.08%
Sep 30, 2025
Ver más

ETFs relacionados

Nombre
Proporción
Sin datos

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI